Finance

Lists
Why is 002581 down 3,52%?
Dive Deeper
002581:SHE
Shandong Sinobioway Biomedicine Co Ltd
CNÂ¥4,93
-3,52%
(-0,18) 1D
15 Okt., 15:04:54 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002581...
Open
CNÂ¥5,01
High
CNÂ¥5,15
Low
CNÂ¥4,91
Mkt. cap
3,44 mjd
Avg. vol.
7,59 m
Volume
3,29 m
52-wk high
CNÂ¥9,17
52-wk low
CNÂ¥3,04
EPS
-CNÂ¥0,22
Shares outstanding
659,74 m
No. of employees
492
Open
CNÂ¥5,01
High
CNÂ¥5,15
Low
CNÂ¥4,91
Mkt. cap
3,44 mjd
Avg. vol.
7,59 m
Volume
3,29 m
52-wk high
CNÂ¥9,17
52-wk low
CNÂ¥3,04
EPS
-CNÂ¥0,22
Shares outstanding
659,74 m
No. of employees
492
News stories
From web sources and news partners
About Shandong Sinobioway Biomedicine Co Ltd
CEO-
Employees492
Founded1998
Headquarters-
SectorPharmaceutical industry
Websitesinobiowaymed.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
141,28 m
62,76 m
43,86 m
50,17 m
Cost of goods sold
109,87 m
19,95 m
37,93 m
48,07 m
Cost of revenue
109,87 m
19,95 m
37,93 m
48,07 m
Research and development expenses
6,09 m
3,52 m
4,10 m
2,51 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
56,51 m
79,90 m
42,51 m
52,03 m
Operating expense
68,68 m
98,18 m
47,61 m
59,51 m
Total operating expenses
178,55 m
118,13 m
85,54 m
107,58 m
Operating income
-37,27 m
-55,37 m
-41,68 m
-57,41 m
Other non operating income
72,91 k
175,90 k
-
-484,03 k
EBT including unusual items
-6,42 m
-72,94 m
-58,73 m
-47,34 m
EBT excluding unusual items
-21,46 m
-53,12 m
-41,55 m
-58,14 m
Income tax expense
-584,79 k
-6,10 m
-541,93 k
-468,59 k
Effective tax rate
9,10%
8,37%
0,92%
0,99%
Other operating expenses
1,56 m
1,91 m
1,34 m
1,51 m
Net income
-1,51 m
-47,47 m
-54,23 m
-41,24 m
Net profit margin
-1,07%
-75,64%
-123,63%
-82,20%
Earnings per share
-
-
-
-
Interest and investment income
15,74 m
3,19 m
131,26 k
600,77 k
Interest expense
-
-1,12 m
-
-850,38 k
Net interest expenses
15,74 m
2,07 m
131,26 k
-249,61 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-26,98 m
-45,97 m
-32,28 m
-48,12 m
Gain or loss from assets sale
691,12 k
-3,82 m
-
-745,24 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme